StonvexLoading…
StonvexStonvexStonvexCore line items from MYPS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $235.10M | $289.43M | $310.89M | $290.31M |
Operating Income | $-23.92M | $-32.86M | $-10.49M | $-28.08M |
Net Income | $-28.64M | $-28.69M | $-19.39M | $-17.78M |
EPS (Diluted) | $-0.23 | $-0.22 | $-0.15 | $-0.14 |
Total Assets | $290.62M | $322.95M | $366.32M | $352.01M |
Total Liabilities | $62.75M | $78.24M | $77.97M | $49.70M |
Cash & Equivalents | $104.94M | $109.18M | $132.89M | $134.00M |
Free Cash Flow OCF − CapEx | $25.37M | $41.76M | $45.39M | $21.41M |
Shares Outstanding | 125.68M | 129.44M | 132.98M | 128.35M |